Hyundai Bioscience Co. Ltd Cash Flow Reinvestment Rate
Hyundai Bioscience Co. Ltd cash flow reinvestment rate. Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Reinvestment Rate of 1.11x as of December 2024, reinvesting ₩2.52 Billion (capex ₩2.17 Billion plus investments ₩-345.74 Million) from operating cash flow of ₩2.26 Billion. Explore Hyundai Bioscience Co. Ltd (048410) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hyundai Bioscience Co. Ltd (2008–2024)
Cash flow reinvestment rate of Hyundai Bioscience Co. Ltd from 2008 to 2024. Historical reinvestment intensity for Hyundai Bioscience Co. Ltd across 8 annual periods. Explore 048410 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hyundai Bioscience Co. Ltd Cash Flow Reinvestment Rate by Year (2008–2024)
Hyundai Bioscience Co. Ltd cash flow reinvestment rate by year from 2008 to 2024. Year-by-year capital reinvestment analysis for Hyundai Bioscience Co. Ltd. For the full cash flow conversion analysis, see how efficiently does Hyundai Bioscience Co. Ltd generate cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 9.71x | ₩21.91 Billion | ₩2.26 Billion | ₩2.17 Billion | ▲ +178.5% |
| 2020 | 3.49x | ₩26.15 Billion | ₩7.50 Billion | ₩25.20 Billion | ▲ +433.9% |
| 2019 | 0.65x | ₩5.99 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -67.3% |
| 2018 | 2.00x | ₩9.99 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -95.2% |
| 2015 | 41.75x | ₩3.65 Billion | ₩87.36 Million | ₩647.57 Million | ▲ +3034.7% |
| 2014 | 1.33x | ₩1.63 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +1874.4% |
| 2011 | 0.07x | ₩267.78 Million | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩3.92 Billion | ₩10.37 Billion | ₩3.92 Billion | — |